{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:47:11Z","timestamp":1773874031650,"version":"3.50.1"},"reference-count":60,"publisher":"American Society of Consultant Pharmacists","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2011,6,1]]},"DOI":"10.4140\/tcp.n.2011.414","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T01:52:34Z","timestamp":1306893154000},"page":"414-425","source":"Crossref","is-referenced-by-count":34,"title":["Medication-Induced Sleep Disturbances"],"prefix":"10.4140","volume":"26","author":[{"given":"Pamela","family":"Foral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Knezevich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naresh","family":"Dewan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Malesker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"1","first-page":"417","article-title":"Medications as a cause of sleep disturbances","volume":"17","author":"PA Foral","year":"2002","journal-title":"Consult Pharm"},{"key":"2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jsmc.2006.06.006","article-title":"Epidemiology of insomnia: from adolescence to old age","volume":"1","author":"E. Johnson","year":"2006","journal-title":"Sleep Med Clin"},{"key":"3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0733-8619(05)70287-5","article-title":"Effects of drugs on sleep","volume":"14","author":"WH Obermeyer","year":"1996","journal-title":"Neurol Clin"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Meyer T. Evaluation and management of insomnia. Hosp Pract 1998:75-86.","DOI":"10.3810\/hp.1998.12.122"},{"key":"5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/bmj.306.6877.573","article-title":"ABC of sleep disorders. Recreational Drugs and Sleep","volume":"306","author":"JR. Stradling","year":"1993","journal-title":"BMJ"},{"key":"6","unstructured":"Thomson Reuters I. Micromedex Healthcare Series. Available at <a target=\"_blank\" href='http:\/\/thomsonreuters.com\/products_services\/healthcare\/healthcare_products\/clinical_deci_support\/micromedex_clinical_evidence_sol\/'>http:\/\/thomsonreuters.com\/products_services\/healthcare\/healthcare_products\/clinical_deci_support\/micromedex_clinical_evidence_sol\/<\/a>"},{"key":"7","first-page":"617","article-title":"Daytime drowsiness: is a drug to blame?","volume":"19","author":"D Cender","year":"1998","journal-title":"J Respir Dis"},{"key":"8","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bmj.306.6888.1331","article-title":"ABC of sleep disorders. Psychotropic drugs and sleep","volume":"306","author":"J Eisen","year":"1993","journal-title":"BMJ"},{"key":"9","unstructured":"Schweitzer PK. Drugs that disturb sleep and wakefulness. In Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, PA: WB Saunders Company; 2000:441-61."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Nocturnal seizures and the effects of anticonvulsants on sleep. Current Neurol Neurosci Rep 2008;8:149-54.","DOI":"10.1007\/s11910-008-0024-z"},{"key":"11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccc.2006.02.010","article-title":"Sedative and analgesic medications: risk factors for delirium and sleep disturbances in the critically ill","volume":"22","author":"P Pandharipande","year":"2006","journal-title":"Crit Care Clin"},{"key":"12","first-page":"46","article-title":"Treatment issues related to sleep and depression","volume":"61","author":"M. Thase","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3810\/pgm.2000.03.935","article-title":"Helping patients who say they cannot sleep, practical ways to evaluate and treat insomnia","volume":"107","author":"H. Attarian","year":"2000","journal-title":"Postgrad Med"},{"key":"14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0163-7258(94)90064-7","article-title":"Drugs and the sleep-wakefulness continuum","volume":"61","author":"P. Pascoe","year":"1994","journal-title":"Pharmacol Ther"},{"key":"15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/070674370004500903","article-title":"The effects of antidepressants on sleep in patients with depression","volume":"45","author":"R. Armitage","year":"2000","journal-title":"Can J Psychiatry"},{"key":"16","first-page":"4","article-title":"Mechanism of action of antidepressant medications","volume":"60","author":"J. Feighner","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1087-0792(02)00158-2","article-title":"Sleep in schizophrenia patients and the effects of antipsychotic drugs","volume":"8","author":"JM Monti","year":"2004","journal-title":"Sleep Med Rev"},{"key":"18","first-page":"540","article-title":"Sex, steroids, and sleep: a review","volume":"22","author":"R Manber","year":"1999","journal-title":"Sleep"},{"key":"19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00002018-199716020-00005","article-title":"Drug induced sleep disturbances","volume":"16","author":"M Novak","year":"1997","journal-title":"Drug Safety"},{"key":"20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/bmj.306.6885.1118","article-title":"ABC of sleep disorders. Non-psychotropic drugs and sleep","volume":"306","author":"C Idzikowski","year":"1993","journal-title":"BMJ"},{"key":"21","first-page":"191","article-title":"Diagnosis and treatment of insomnia","volume":"35","author":"JF. Pagel","year":"1987","journal-title":"Am Fam Physician"},{"key":"22","first-page":"33","article-title":"The effect of opioids on sleep architecture","volume":"3","author":"JE Dimsdale","year":"2007","journal-title":"J Clin Sleep Med"},{"key":"23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0031-9384(94)90388-3","article-title":"Nonsteroidal antiinflammatory drugs affect normal sleep patterns in humans","volume":"55","author":"PJ Murphy","year":"1994","journal-title":"Physio Behav"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Analyzing sleep abnormalities in HIV-infected patients treated with efavirenz. Clin Infect Dis 2004;38:430-2.","DOI":"10.1086\/380791"},{"key":"25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/00002512-200623060-00005","article-title":"Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease","volume":"23","author":"JR Cooke","year":"2006","journal-title":"Drugs Aging"},{"key":"26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-151-3-200908040-00127","article-title":"Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events","volume":"151","author":"A Gutierrez-Valencia","year":"2009","journal-title":"Ann Intern Med"},{"key":"27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2125.2008.03310.x","article-title":"Antiparkinsonian druginduced sleepiness: a double-blind placebo controlled study of L-DOPA, bromocriptine, and pramipexole in healthy subjects","volume":"67","author":"J Micallef","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"28","first-page":"476","article-title":"Sleep attacks or unintended sleep episodes occur with dopamine agonists","volume":"25","author":"KR Chaudhuri","year":"2002","journal-title":"Drug Safety"},{"key":"29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.58.3.460","article-title":"Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers","volume":"58","author":"JJ Ferreira","year":"2002","journal-title":"Neurology"},{"key":"30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.58.3.462","article-title":"Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD","volume":"58","author":"M Ulivelli","year":"2002","journal-title":"Neurology"},{"key":"31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.npp.1300298","article-title":"The somatostatin analogue octreotide impairs sleep and decreases EEG sigma power in young male subjects","volume":"29","author":"M Ziegenbein","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5664\/jcsm.27716","article-title":"Pharmacologically induced\/ exacerbated restless leg syndrome, periodic limb movement\/REM sleep without atonia: literature review, qualitative scoring and comparative analysis","volume":"6","author":"R Hoque","year":"2010","journal-title":"J Clin Sleep Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s00415-009-0073-5","article-title":"Restless legs syndrome induced by topiramate: two more cases","volume":"256","author":"PE. Bermejo","year":"2009","journal-title":"J Neurol"},{"key":"34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1212\/WNL.60.1.147","article-title":"Zonisamide-induced restless legs syndrome","volume":"60","author":"JT Chen","year":"2003","journal-title":"Neurology"},{"key":"35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2002-31514","article-title":"Restless legs syndrome probably induced by risperidone treatment","volume":"35","author":"TC Wetter","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mds.20049","article-title":"Restless legs syndrome due to interferon-alpha","volume":"19","author":"JS LaRochelle","year":"2004","journal-title":"Movement Disord"},{"key":"37","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/mds.21449","article-title":"Restless legs syndrome induced by zonisamide","volume":"22","author":"PEB Velasco","year":"2007","journal-title":"Movement Disord"},{"key":"38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsmc.2010.01.007","article-title":"Drugs, dreams and nightmares","volume":"5","author":"JF. Pagel","year":"2010","journal-title":"Sleep Med Clin"},{"key":"39","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/bmj.332.7547.950","article-title":"Atorvastatin may cause nightmares","volume":"332","author":"PJHS. Gregoor","year":"2006","journal-title":"BMJ"},{"key":"40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-2005-867077","article-title":"Psychiatric disorders associated with disturbed sleep","volume":"25","author":"LE. Krahn","year":"2005","journal-title":"Semin Neurol"},{"key":"41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ccm.2010.02.008","article-title":"Medication effects on sleep","volume":"31","author":"FJ Roux","year":"2010","journal-title":"Clin Chest Med"},{"key":"42","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archneur.62.8.1242","article-title":"Sudden uncontrollable somnolence and medication use in Parkinson disease","volume":"62","author":"J Avorn","year":"2005","journal-title":"Arch Neurol"},{"key":"43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.0013-9580.2005.49104.x","article-title":"Hypersomnia in an epilepsy patient treated with levetiracetam","volume":"46","author":"R Khatami","year":"2005","journal-title":"Epilepsia"},{"key":"44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2165\/00023210-200317080-00004","article-title":"Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?","volume":"17","author":"TA Zasiewicz","year":"2003","journal-title":"CNS Drugs"},{"key":"45","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/bmj.324.7352.1483","article-title":"Sleep attacks in patients taking dopamine agonists: review","volume":"324","author":"CN Homann","year":"2002","journal-title":"BMJ"},{"key":"46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1472-8206.2003.00120.x","article-title":"Excessive daytime sleepiness and sleep attacks induced by entacapone","volume":"17","author":"M Bares","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"key":"47","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(00)02119-X","article-title":"Sleep attacks and Parkinson's disease treatment","volume":"335","author":"JJ Ferreira","year":"2000","journal-title":"Lancet"},{"key":"48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ajhp\/62.5.537","article-title":"Sleep attacks in patients receiving dopamine-receptor agonists","volume":"62","author":"BK Plowman","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"49","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1212\/WNL.61.7.1008","article-title":"L-DOPAinduced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment","volume":"61","author":"D Garcia-Borreguero","year":"2003","journal-title":"Neurology"},{"key":"50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199701303360506","article-title":"Management of insomnia","volume":"336","author":"DJ Kupfer","year":"1997","journal-title":"N Engl J Med"},{"key":"51","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.mcna.2010.02.012","article-title":"Insomnia pharmacology","volume":"94","author":"SS. Sullivan","year":"2010","journal-title":"Med Clin North Am"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Gray J, Young B. Acute onset insomnia associated with the initiation of raltegravir: a report of two cases and literature review. AIDS Patient Care STDs 2009;23:689-90.","DOI":"10.1089\/apc.2009.0012"},{"key":"53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ncl.2005.06.002","article-title":"Rapid eye movement sleep parasomnias","volume":"23","author":"CH Schenck","year":"2005","journal-title":"Neurol Clin"},{"key":"54","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/0023210-200822120-00005","article-title":"Hyposedative-induced complex behaviours","volume":"22","author":"CR Dolder","year":"2008","journal-title":"CNS Drugs"},{"key":"55","unstructured":"U.S. Food and Drug Administration. FDA requests label change for all sleep disorder drug products. Available at <a target=\"_blank\" href='http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/2007\/ucm108868.htm'>http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/2007\/ucm108868.htm<\/a>"},{"key":"56","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1176\/appi.ajp.158.7.1158","article-title":"Olanzapineinduced somnambulism","volume":"158","author":"TT Kolivakis","year":"2001","journal-title":"Am J Psychiatry"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Hafeez ZH, Kalinowski CM. Somnambulism induced by quetiapine: two case reports and a review of the literature. CNS Spectr 2007;12:910-2.","DOI":"10.1017\/S1092852900015698"},{"key":"58","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5664\/jcsm.27605","article-title":"Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-fluorodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem","volume":"5","author":"R Hoque","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"59","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/WNF.0b013e318157425a","article-title":"Late-life somnambulism after therapy with metoprolol","volume":"31","author":"J Hensel","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Yeh YW, Chen CH, Feng HM et al. New onset somnambulism associated with different dosage of mirtazapine: a case report. Clin Neuropharmacol 2009;32:232-3.","DOI":"10.1097\/WNF.0b013e318187bafc"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T19:28:33Z","timestamp":1592594913000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2011\/00000026\/00000006\/art00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6,1]]}},"alternative-id":["H8G0J11555Q57434"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2011.414","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}